Clinical trial
AndraValvulotome Post-Market Study
NCT04815473 is registered in ClinicalTrials.gov with Andramed GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AndraValvulotome Post-Market Study
- Lead sponsor
- Andramed GmbH
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- April 28, 2021
- Completion date
- December 31, 2023
- Enrollment
- 59 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.